BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27236066)

  • 1. Kinetic, thermodynamic and structural analysis of tamiphosphor binding to neuraminidase of H1N1 (2009) pandemic influenza.
    Albiñana CB; Machara A; Řezáčová P; Pachl P; Konvalinka J; Kožíšek M
    Eur J Med Chem; 2016 Oct; 121():100-109. PubMed ID: 27236066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamiphosphor monoesters as effective anti-influenza agents.
    Chen CL; Lin TC; Wang SY; Shie JJ; Tsai KC; Cheng YS; Jan JT; Lin CJ; Fang JM; Wong CH
    Eur J Med Chem; 2014 Jun; 81():106-18. PubMed ID: 24836064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus.
    Pokorná J; Pachl P; Karlukova E; Hejdánek J; Řezáčová P; Machara A; Hudlický J; Konvalinka J; Kožíšek M
    Viruses; 2018 Jun; 10(7):. PubMed ID: 29933553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactose-conjugates of the oseltamivir pharmacophore--new tools for the characterization of influenza virus neuraminidases.
    Carbain B; Martin SR; Collins PJ; Hitchcock PB; Streicher H
    Org Biomol Chem; 2009 Jun; 7(12):2570-5. PubMed ID: 19503932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain.
    Hussain Basha S; Prasad RN
    BMC Res Notes; 2012 Feb; 5():105. PubMed ID: 22340192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
    Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme.
    Bantia S; Upshaw R; Babu YS
    Antiviral Res; 2011 Sep; 91(3):288-91. PubMed ID: 21722670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
    Singh A; Soliman ME
    Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
    Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
    Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase.
    Liu H; Yao X; Wang C; Han J
    Mol Pharm; 2010 Jun; 7(3):894-904. PubMed ID: 20420444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-linked inhibitor antibody assay (DIANA) as a new method for screening influenza neuraminidase inhibitors.
    Kožíšek M; Navrátil V; Rojíková K; Pokorná J; Berenguer Albiñana C; Pachl P; Zemanová J; Machara A; Šácha P; Hudlický J; Císařová I; Řezáčová P; Konvalinka J
    Biochem J; 2018 Dec; 475(23):3847-3860. PubMed ID: 30404922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.
    Woods CJ; Malaisree M; Pattarapongdilok N; Sompornpisut P; Hannongbua S; Mulholland AJ
    Biochemistry; 2012 May; 51(21):4364-75. PubMed ID: 22574858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
    Udommaneethanakit T; Rungrotmongkol T; Bren U; Frecer V; Stanislav M
    J Chem Inf Model; 2009 Oct; 49(10):2323-32. PubMed ID: 19780597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition.
    Vavricka CJ; Li Q; Wu Y; Qi J; Wang M; Liu Y; Gao F; Liu J; Feng E; He J; Wang J; Liu H; Jiang H; Gao GF
    PLoS Pathog; 2011 Oct; 7(10):e1002249. PubMed ID: 22028647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
    ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations.
    Pan P; Li L; Li Y; Li D; Hou T
    Antiviral Res; 2013 Nov; 100(2):356-64. PubMed ID: 24055835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
    Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J
    Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
    Hurt AC; Deng YM; Ernest J; Caldwell N; Leang L; Iannello P; Komadina N; Shaw R; Smith D; Dwyer DE; Tramontana AR; Lin RT; Freeman K; Kelso A; Barr IG
    Euro Surveill; 2011 Jan; 16(3):. PubMed ID: 21262183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of NH
    Wang K; Yang F; Wang L; Liu K; Sun L; Lin B; Hu Y; Wang B; Cheng M; Tian Y
    Eur J Med Chem; 2017 Dec; 141():648-656. PubMed ID: 29107426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.